Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants-a prospective cohort study (RESCUE-TX).
Reindl-Schwaighofer R, Heinzel A, Raab L, Strassl R, Herz CT, Regele F, Doberer K, Helk O, Spechtl P, Aschauer C, Hu K, Jagoditsch R, Reiskopf B, Böhmig GA, Benka B, Mahr B, Stiasny K, Weseslindtner L, Kammer M, Wekerle T, Oberbauer R. Reindl-Schwaighofer R, et al. Among authors: raab l. EBioMedicine. 2024 Nov;109:105417. doi: 10.1016/j.ebiom.2024.105417. Epub 2024 Oct 22. EBioMedicine. 2024. PMID: 39442367 Free PMC article.
Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination-A Non-randomized, Controlled Pilot Study.
Regele F, Heinzel A, Hu K, Raab L, Eskandary F, Faé I, Zelzer S, Böhmig GA, Bond G, Fischer G, Oberbauer R, Reindl-Schwaighofer R. Regele F, et al. Front Med (Lausanne). 2022 Jun 10;9:914424. doi: 10.3389/fmed.2022.914424. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35755078 Free PMC article.
Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial.
Heinzel A, Schrezenmeier E, Regele F, Hu K, Raab L, Eder M, Aigner C, Jabbour R, Aschauer C, Stefanski AL, Dörner T, Budde K, Reindl-Schwaighofer R, Oberbauer R. Heinzel A, et al. Front Med (Lausanne). 2022 Jul 22;9:936126. doi: 10.3389/fmed.2022.936126. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35935786 Free PMC article.
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial.
Heinzel A, Schrezenmeier E, Regele F, Hu K, Raab L, Eder M, Aigner C, Jabbour R, Aschauer C, Stefanski AL, Dörner T, Budde K, Reindl-Schwaighofer R, Oberbauer R. Heinzel A, et al. Among authors: raab l. Front Med (Lausanne). 2022 Oct 10;9:1048395. doi: 10.3389/fmed.2022.1048395. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36300193 Free PMC article.
Repeat ABO-B-incompatible living-donor kidney transplantation.
Daoudi I, Heinzel A, Fischer G, Wagner L, Halpin A, West L, Motyka B, Raab L, Reindl-Schwaighofer R, Oberbauer R. Daoudi I, et al. Among authors: raab l. Nephrol Dial Transplant. 2026 Jan 30;41(2):388-391. doi: 10.1093/ndt/gfaf246. Nephrol Dial Transplant. 2026. PMID: 41206771 Free PMC article. No abstract available.
34 results